Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Suspended  
  • Page 1 ·  Next »

NCT ID: NCT03020784 Suspended - Healthy Clinical Trials

Safety and Tolerability of PF-06818883 in Healthy Subjects

Start date: November 11, 2016
Phase: Phase 1
Study type: Interventional

Safety, Tolerability and Pharmacokinetics of PF-06818883

NCT ID: NCT02696616 Suspended - Healthy Clinical Trials

Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers

Start date: March 2016
Phase: Phase 1
Study type: Interventional

Investigation of safety and tolerability of BI 655088 following intravenous infusion of single rising doses and exploration of the pharmacokinetics and pharmacodynamics of BI 655088 after single dosing

NCT ID: NCT02621671 Suspended - Healthy Clinical Trials

Communicating Multiple Disease Risks

Start date: April 1, 2015
Phase: Phase 1
Study type: Interventional

Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences. The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health. The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.

NCT ID: NCT02289404 Suspended - Healthy Clinical Trials

Evaluate the Food Effect on the Pharmacokinetics of NVP-1203

NVP-1203
Start date: January 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to Evaluate food effect of NVP-1203 in healthy Korean male adults.

NCT ID: NCT02289274 Suspended - Healthy Clinical Trials

Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203

NVP-1203
Start date: December 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the pharmacokinetics of NVP-1203 and coadministration of aceclofenac and eperisone HCl SR.

NCT ID: NCT02091817 Suspended - Healthy Clinical Trials

The Effect of Oxytocin on Face Perception

Start date: November 2013
Phase: Phase 0
Study type: Interventional

The purpose of this study is to determine whether oxytocin affect face perception

NCT ID: NCT01760980 Suspended - Healthy Clinical Trials

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

Start date: November 2012
Phase: Phase 1
Study type: Interventional

The objective of this study is to assess the bioequivalence of the test product, Exemestane 25 mg tablets of Actavis Group PTC ehf. Iceland, and the reference product, Aromasin® (exemestane) 25 mg tablets of Pharmacia & Upjohn Company, Division of Pfizer Inc., New York, United States of America in healthy male and postmenopausal female subjects, under fasting conditions

NCT ID: NCT01340183 Suspended - Healthy Clinical Trials

Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects

Start date: May 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of the drug AZD5099 after intravenous administration of single doses in healthy volunteers. The results from this study will form the basis for decisions regarding the future development of AZD5099 as a novel antibiotic for the treatment of serious infections in humans.

NCT ID: NCT00684333 Suspended - Healthy Clinical Trials

Safety and Efficacy of EZ-Ject Injector a Pain-Free Subcutaneous Automatic Injection in Healthy Volunteers

Start date: June 2009
Phase: N/A
Study type: Interventional

Subcutaneous injections are a widely used method for drug delivery. One of its major drawbacks is the pain inflicted during the process. Sindolor has developed the chemical-free EZ-Ject Injector device, based on employing cutaneous local anesthesia on the injection site by an electronic anesthetic system. The purpose of this study is to determine the safety and efficacy of the EZ-Ject for subcutaneous injections.

NCT ID: NCT00623675 Suspended - Healthy Clinical Trials

Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox

Start date: February 2008
Phase: Phase 4
Study type: Interventional

Researchers want to find out if urine heavy metal levels are changed in persons who use Mineralox Basic C™ (Mineralox). Mineralox is a zeolite (clinoptilolite) in combination with Vitamin C. Zeolites are natural supplements (nutraceuticals) that work at the cellular level to remove heavy metals and toxins that are accumulated in every day life safely from the body through the urine. The study doctor will give Mineralox to 20 people in this study to see if it helps with the heavy metal removal from the body.